Transmission and immunopathogenesis of FIV in cats as a model for HIV

被引:103
作者
Burkhard, MJ [1 ]
Dean, GA [1 ]
机构
[1] N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC 27606 USA
关键词
FIV; immunopathogenesis; HIV animal model; mucosal transmission; feline; FELINE IMMUNODEFICIENCY VIRUS; CHEMOKINE RECEPTOR CXCR4; LONG TERMINAL REPEAT; AP-1; BINDING-SITE; BLOOD MONONUCLEAR-CELLS; POLYMERASE-CHAIN-REACTION; CYTOTOXIC T-LYMPHOCYTES; IN-VIVO REPLICATION; FREE-RANGING LIONS; PRODUCTIVE INFECTION;
D O I
10.2174/1570162033352101
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The feline immunodeficiency virus (FIV) model provides a system to study lentivirus transmission, virus kinetics, pathogenesis, host responses, and immune dysfunction in a natural, out-bred host, under controlled conditions with specific-pathogen-free animals. The diversity of primary FIV strains can be exploited to mirror the range of disease manifestations associated with HIV infection. FIV is infectious via intravenous, intraperitoneal, intradermal, or subcutaneous injection as well as by atraumatic instillation onto the oral, vaginal, or rectal mucosa. Together, these features allow investigators to model specific aspects of HIV infection in a highly relevant and relatively inexpensive animal model. Well-developed areas of the FIV model include: (1) transmission of cell-associated as well as cell-free virus; (2) mucosal infectivity and immunopathogenesis; (3) vertical transmission; (4) acquired immunodeficiency including defects of the innate immune system; (5) thymic dysfunction; (6) neurotropism and neuropathogenesis; (7) host-virus interactions and the role of specific gene products; (8) efficacy of antiviral therapy; and (9) efficacy and immune correlates of experimental vaccines. This review will encompass areas specific to transmission and immunopathogenesis.
引用
收藏
页码:15 / 29
页数:15
相关论文
共 256 条
[1]  
ANDERSON DJ, 1990, ARCH IMMUNOL THER EX, V38, P79
[2]   Genetic diversity of feline immunodeficiency virus: Dual infection, recombination, and distinct evolutionary rates among envelope sequence clades [J].
Bachmann, MH ;
MathiasonDubard, C ;
Learn, GH ;
Rodrigo, AG ;
Sodora, DL ;
Mazzetti, P ;
Hoover, EA ;
Mullins, JI .
JOURNAL OF VIROLOGY, 1997, 71 (06) :4241-4253
[3]   SERUM NEUTRALIZATION OF FELINE IMMUNODEFICIENCY VIRUS IS MARKEDLY DEPENDENT ON PASSAGE HISTORY OF THE VIRUS AND HOST SYSTEM [J].
BALDINOTTI, F ;
MATTEUCCI, D ;
MAZZETTI, P ;
GIANNELLI, C ;
BANDECCHI, P ;
TOZZINI, F ;
BENDINELLI, M .
JOURNAL OF VIROLOGY, 1994, 68 (07) :4572-4579
[4]  
BARLOUGH JE, 1991, J ACQ IMMUN DEF SYND, V4, P219
[5]   ISOLATION OF A HIGHLY CYTOPATHIC LENTIVIRUS FROM A NONDOMESTIC CAT [J].
BARR, MC ;
ZOU, L ;
HOLZSCHU, DL ;
PHILLIPS, L ;
SCOTT, FW ;
CASEY, JW ;
AVERY, RJ .
JOURNAL OF VIROLOGY, 1995, 69 (11) :7371-7374
[6]   Exogenous glucocorticoids alter parameters of early feline immunodeficiency virus infection [J].
Barr, MC ;
Huitron-Resendiz, S ;
Selway, DR ;
Henriksen, SJ ;
Phillips, TR .
JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (02) :576-586
[7]  
BARR MC, 1989, J ZOO WILDLIFE MED, V20, P265
[8]   Feline immunodeficiency virus (FIV)-associated lymphoma: a potential role for immune dysfunction in tumourigenesis [J].
Beatty, JA ;
Lawrence, CE ;
Callanan, JJ ;
Grant, CK ;
Gault, EA ;
Neil, JC ;
Jarrett, O .
VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 1998, 65 (2-4) :309-322
[9]   Molecular and immunophenotypical characterization of a feline immunodeficiency virus (FIV)-associated lymphoma: a direct role for FIV in B-lymphocyte transformation? [J].
Beatty, JA ;
Callanan, JJ ;
Terry, A ;
Jarrett, O ;
Neil, JC .
JOURNAL OF VIROLOGY, 1998, 72 (01) :767-771
[10]   A longitudinal study of feline immunodeficiency virus-specific cytotoxic T lymphocytes in experimentally infected cats, using antigen-specific induction [J].
Beatty, JA ;
Willett, BJ ;
Gault, EA ;
Jarrett, O .
JOURNAL OF VIROLOGY, 1996, 70 (09) :6199-6206